UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Pathogenetic mechanisms of amyloid A amyloidosis

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (40), p.16115-16120

2013

Volltextzugriff (PDF)

Transgenic Human C-Reactive Protein Is Not Proatherogenic in Apolipoprotein E-Deficient Mice

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (23), p.8309-8314

2005

Volltextzugriff (PDF)

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (18), p.7619-7623

2009

Volltextzugriff (PDF)

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

Nature (London), 1997-02, Vol.385 (6619), p.787-793

1997

Volltextzugriff (PDF)

Immunoradiometric Assay of Circulating C-Reactive Protein: Age-related Values in the Adult General Population

Clinical chemistry (Baltimore, Md.), 2000-07, Vol.46 (7), p.934-938

2000

Volltextzugriff (PDF)

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

Nature (London), 2010-11, Vol.468 (7320), p.93-97

2010

Volltextzugriff (PDF)

Association between C-reactive protein and features of the metabolic syndrome

Diabetes care, 2000-12, Vol.23 (12), p.1835

2000

Volltextzugriff (PDF)

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

British journal of haematology, 2010-03, Vol.148 (5), p.760-767

2010

Volltextzugriff (PDF)

C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992

Circulation (New York, N.Y.), 1999-01, Vol.99 (2), p.237-242

1999

Volltextzugriff (PDF)

C‐reactive protein is essential for innate resistance to pneumococcal infection

Immunology, 2014-07, Vol.142 (3), p.414-420

2014

Volltextzugriff (PDF)

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice

Atherosclerosis, 2008-01, Vol.196 (1), p.248-255

2008

Volltextzugriff (PDF)

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use

Journal of immunological methods, 2012-10, Vol.384 (1-2), p.92-102

2012

Volltextzugriff (PDF)

Lack of seasonal variation in C-reactive protein

Clinical chemistry (Baltimore, Md.), 2002-03, Vol.48 (3), p.575-577

2002

Volltextzugriff (PDF)

Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987

American journal of epidemiology, 2003-08, Vol.158 (4), p.357-364

2003

Volltextzugriff (PDF)

Immunoradiometric assay for human serum amyloid P component

Journal of immunological methods, 2011-08, Vol.371 (1-2), p.18-24

2011

Volltextzugriff (PDF)

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Nature medicine, 1997-08, Vol.3 (8), p.855-859

1997

Volltextzugriff (PDF)

Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Immunology, 2004-06, Vol.112 (2), p.255-264

2004

Volltextzugriff (PDF)

Is leptin an important physiological regulator of CRP?

Nature medicine, 2007-01, Vol.13 (1), p.17-18

2007

Volltextzugriff (PDF)

Determination of C-reactive protein: comparison of three high-sensitivity immunoassays

Clinical chemistry (Baltimore, Md.), 2003-10, Vol.49 (10), p.1691-1695

2003

Volltextzugriff (PDF)

Human serum amyloid P component is a single uncomplexed pentamer in whole serum

Molecular medicine (Cambridge, Mass.), 2000-06, Vol.6 (6), p.482-493

2000

Volltextzugriff (PDF)

P2-307: CPHPC depletes serum amyloid P component from the cerebrospinal fluid in Alzheimer's disease

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T462-T462

2008

Volltextzugriff (PDF)

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

Diabetes care, 2000-12, Vol.23 (12), p.1835-1839

2000

Volltextzugriff (PDF)

Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice

Immunology, 2004-06, Vol.112 (2), p.250-254

2004

Volltextzugriff (PDF)

Fucosyltransferases : differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis

Hepatology (Baltimore, Md.), 1991-04, Vol.13 (4), p.683-688

1991

Volltextzugriff (PDF)

Influenza virus infection is not affected by serum amyloid P component

Molecular medicine (Cambridge, Mass.), 2002-01, Vol.8 (1), p.9-15

2002

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(40)
Buchkapitel
(2)

Sprache

Englisch
(42)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathogenetic mechanisms of amyloid A amyloidosis

Transgenic Human C-Reactive Protein Is Not Proatherogenic in Apolipoprotein E-Deficient Mice

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

Immunoradiometric Assay of Circulating C-Reactive Protein: Age-related Values in the Adult General Population

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

Association between C-reactive protein and features of the metabolic syndrome

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992

C‐reactive protein is essential for innate resistance to pneumococcal infection

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use

Lack of seasonal variation in C-reactive protein

Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987

Immunoradiometric assay for human serum amyloid P component

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Is leptin an important physiological regulator of CRP?

Determination of C-reactive protein: comparison of three high-sensitivity immunoassays

Human serum amyloid P component is a single uncomplexed pentamer in whole serum

P2-307: CPHPC depletes serum amyloid P component from the cerebrospinal fluid in Alzheimer's disease

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice

Fucosyltransferases : differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis

Influenza virus infection is not affected by serum amyloid P component

Suchergebnisse filtern